Clinical Trials List
2014-04-01 - 2017-01-01
Phase II
Terminated7
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Rheun-Chuan Lee Division of Hematology & Oncology
- Yi-Hsiang Huang Division of Hematology & Oncology
- Yi-Chen Yeh Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Chien-Wei Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃文冠 Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳彥仰 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 盧勝男 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- Jing-Houng Wang Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 洪肇宏 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 官鋒澤 Division of Hematology & Oncology
- 沈建亨 Division of Hematology & Oncology
- 呂長賢 Division of Hematology & Oncology
- 陳苡揚 Division of Hematology & Oncology
- 許勝榮 Division of Hematology & Oncology
- 黃慈恩 Division of Hematology & Oncology
- 王鼎堯 Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- 蕭如豐 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
120 participants
